More on IMS Q2 results

IMS Health Holdings (NYSE:IMS) Q2 results: Revenue: $662M (+6.1%), Information: $386M (+1.8%), Technology Services: $276M (+12.7%); Cost of Services: $314M (+11.7%); SG&A Expense: $247M (+70.3%); Operating Income/Loss: ($39M) (-140.2%); Net Income/Loss: ($220M) (-999%); EPS: ($0.67) (-999%); Quick Assets: $266M (-63.5%); CF Ops: ($126M) (-200.0%).

2014 Guidance: Revenue growth: 5 - 6%; adjusted EBITDA growth: 7.5 - 9%; adjusted net income growth: 15 - 20%.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs